Home > Home > Buzzkill alert: Israeli company grows marijuana…

Buzzkill alert: Israeli company grows marijuana that won’t get you high

Many people will read the headline and beg the answer to why such problem needed to be addressed. We promise, however, that there may just be a group of people who will find some benefits to a new strain of cannabis that is designed to not get you high.

Grown in an undisclosed location in Tzfat, northern Israel, Tikum Olam is a government-approved medical marijuana plantation that has developed a new type of marijuana with low traces of tetrahydrocannabinol (THC). THC is the active chemical that gets people high off weed in the first place, making it difficult for those who require medical marijuana throughout the day to focus. This means without feeling stoned, this new strain known as Avidekel offers medical marijuana patients the chance to get on with their lives without the intoxicating effects — especially if they are working or driving.

“Sometimes the high is not always what they need. Sometimes it is an unwanted side effect. For some of the people it’s not even pleasant,” said Zack Klein, head of development at Tikun Olam.

It is scientifically shown that some of the more active constituents of marijuana, aside from THC, is cannabidiol (CBD). This chemical is believed by researchers to offer pain relief without the potent and intoxicating effects of THC, therefore a balance of THC and CBD concentration can help make marijuana less likely to get you high. After three years of research, Tikum Olam finally arrived to the chemical makeup of Avidekel which contains less than one percent of THC concentration. To give you some insight, a typical THC level for the average marijuana can range anywhere between 0.4 to 4 percent, or as high as 15 percent for the more expensive stuff, reports How Stuff Works. With the help of 15.8 percent CBD concentration in Avidekel, the marijuana is still medically effective without the psychoactive potency effect.

Although the high is a side effect commonly welcomed by medical marijuana users (and recreational users alike), some patients do say they look forward to an alternative strain. “It’s a huge advantage,” said a 35-year-old patient, one of the ten who who began using Avidekel in the last six months, to Reuters. “I can smoke during the day, function with a lot less pain and still be focused, work and drive. It is a great gift.”

We can’t say when Avidekel may arrive to international markets, but given the weed culture in America we’re also not sure if such strain will take off all too popularly here. But hey, don’t say you didn’t have the option. Wonder if they’ll be available via a vending machine?

Get our Top Stories delivered to your inbox: